Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?


Kamasak T. , TÜREDİ S. , Serin H. M. , MENTEŞE A. , GÜNDÜZ A. , ALVER A. , ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, ss.282-286, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 47 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1504-105
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.282-286

Özet

Background/aim: In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.